Benzinga  1 hr ago  Comment 
Morgan Stanley downgraded Athenahealth, Inc (NASDAQ: ATHN) to Equal-Weight from Overweight as the company’s transition to value-based system is weighing on bookings and revenue growth. Amid declining government subsidies and reimbursement...
Clusterstock  4 hrs ago  Comment 
The Department of Health and Human Services announced Monday that the cost for a health-insurance plan obtained through the exchanges set up by the Affordable Care Act, the healthcare law better known as Obamacare, would increase by 25% on average...
Benzinga  5 hrs ago  Comment 
  athenahealth, Inc (NASDAQ: ATHN) shares touched a new 52-week low of $105. Morgan Stanley downgraded athenahealth from Overweight to Equal-Weight and lowered the price target from $153.00 to $117.00. Aptose Biosciences Inc (NASDAQ:...
Clusterstock  Oct 25  Comment 
One side effect of all that fury over the price of the EpiPen seems to be a jump in prescriptions for the drug. Mylan, the maker of the device used to treat severe allergic reactions, came under fire in late August for the fact that the drug's...
Forbes  Oct 24  Comment 
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in PACCAR Inc. (NASD: PCAR), where a total of 6,182 contracts have traded so far, representing approximately 618,200 underlying shares. That...
Benzinga  Oct 24  Comment 
The following stocks posted three-day sell offs on increasing volume spanning the trading days from October 19 to October 21: Adverum Biotechnologies Inc (NASDAQ: ADVM) athenahealth, Inc (NASDAQ: ATHN) Dorman Products Inc. (NASDAQ:...
Motley Fool  Oct 21  Comment 
Controlling costs were a key factor in boosting the healthcare technology provider's earnings in Q3.
newratings.com  Oct 20  Comment 
WASHINGTON (dpa-AFX) - Athenahealth, Inc. (ATHN) reported earnings for its third quarter that rose compared to the same period last year. The company said its bottom line climbed to $24.09 million, or $0.60 per share. This was higher than $14.30...


Company Overview

Financial Analysis

Business Segments

Geographic Regions

Key Trends and Forces



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki